Scribble

AIDX share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Price change

The price of AIDX shares has increased $0.00 since the market last closed. This is a 1.03% rise.
Last closed at $0.47.

The stock has since dropped $0.01 in pre-market trading.

Key terms

20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is headquartered in Gaithersburg, MD.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Market cap: $6.00M

A market capitalization up to $300 million places AIDX in the micro-capitalization category.

Key terms

Smart score

May 22, 2026 3:55pm ET 20/20 Biolabs: Buy Rating Reiterated on Growth Outlook and OneTest Momentum; $5 Price Target Maintained by TipRanks May 22, 2026 8:48am ET 20/20 BioLabs develops contingency plans to establish Ebola, Hantavirus by TipRanks May 12, 2026 10:02am ET 20/20 BioLabs enters licensing agreement with University of South Carolina by TipRanks May 11, 2026 11:28am ET 20/20 BioLabs initiated with a Buy at Maxim by TipRanks May 08, 2026 12:50pm ET Analysts Are Bullish on Top Healthcare Stocks: Pacific Biosciences (PACB), 20/20 Biolabs, Inc. (AIDX) by TipRanks Apr 06, 2026 5:35pm ET 20/20 BioLabs files to sell 10.1M shares of common stock for holders by TipRanks Mar 27, 2026 8:57am ET 20/20 BioLabs announces grants for Maryland fire departments to procure OneTest by TipRanks Mar 24, 2026 8:46am ET 20/20 BioLabs enters exclusive technology license, access agreement with Rokit by TipRanks Mar 23, 2026 4:50pm ET Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH) and 20/20 Biolabs, Inc. (AIDX) by TipRanks Mar 20, 2026 2:10pm ET Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Cingulate Inc (CING) by TipRanks Mar 16, 2026 11:10am ET Opening Day: SoftBank payments app operator makes public debut by TipRanks Mar 12, 2026 8:50am ET 20/20 BioLabs provides update on protein biomarket technology for MCED by TipRanks Mar 11, 2026 12:10pm ET Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Biogen (BIIB) by TipRanks Feb 25, 2026 10:10am ET 20/20 Biolabs, Inc. Common Stock trading resumes by TipRanks Feb 25, 2026 10:00am ET 20/20 Biolabs, Inc. Common Stock trading halted, volatility trading pause by TipRanks Feb 25, 2026 8:54am ET 20/20 BioLabs announces launch, commercial availability of OneTest by TipRanks Feb 23, 2026 11:10am ET Opening Day: Three AI-focused newcomers make market debuts by TipRanks Feb 23, 2026 9:40am ET 20/20 Biolabs, Inc. Common Stock trading resumes by TipRanks Feb 23, 2026 9:35am ET 20/20 Biolabs, Inc. Common Stock trading halted, volatility trading pause by TipRanks

1-year income & revenue

Total revenue: $2.04M (1Y), $730.57K (Q2)

Total Revenue increased 16.71% since last year and increased 106.74% since last quarter.
Net income: -$3.74M (1Y), -$1.51M (Q2)

Net Income increased 32.65% since last year and increased 30.74% since last quarter.
Earnings per share: -$0.36 (1Y), -$0.22 (Q2)

EPS increased 69.14% since last year and decreased 10.64% since last quarter.

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

How competitors are chosen

AIDX's competitors are included in the Health Services sector and Medical/Nursing Services group
Market cap: $6.00M

A market capitalization up to $300 million places AIDX in the micro-capitalization category.